Edition:
India

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

98.66USD
11:29pm IST
Change (% chg)

$1.54 (+1.59%)
Prev Close
$97.12
Open
$97.71
Day's High
$98.82
Day's Low
$97.51
Volume
188,167
Avg. Vol
325,333
52-wk High
$112.83
52-wk Low
$90.14

Chart for

About

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower... (more)

Overall

Beta: 0.59
Market Cap(Mil.): $12,606.60
Shares Outstanding(Mil.): 136.41
Dividend: 0.45
Yield (%): 1.95

Financials

BRIEF-Fresenius Medical Care Closes Divestment Of Shiel Medical Laboratory To Quest Diagnostics

* DGAP-NEWS: FRESENIUS MEDICAL CARE CLOSES DIVESTMENT OF SHIEL MEDICAL LABORATORY TO QUEST DIAGNOSTICS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

12 Dec 2017

Medical lab trade group sues over U.S. reimbursement cuts

A U.S. trade association representing medical laboratories filed a lawsuit on Monday challenging a new reimbursement system used by the federal government that it said would reduce how much Medicare pays for labs by about $670 million in 2018.

12 Dec 2017

Medical lab trade group sues over U.S. reimbursement cuts

Dec 11 A U.S. trade association representing medical laboratories filed a lawsuit on Monday challenging a new reimbursement system used by the federal government that it said would reduce how much Medicare pays for labs by about $670 million in 2018.

12 Dec 2017

BRIEF-Quest Diagnostics provides update on impact of 2018 Medicare payment rates

* Quest Diagnostics provides update on impact of final 2018 Medicare payment rates for clinical laboratory tests

21 Nov 2017

Reimbursement cuts on lab tests pressure U.S. lab firm shares

A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies.

20 Nov 2017

Reimbursement cuts on lab tests pressure US lab firm shares

Nov 20 A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies.

20 Nov 2017

BRIEF-FDA approves Clinical Genomics, Quest Diagnostics Insure One

* Clinical Genomics and Quest Diagnostics announce FDA 510(k) clearance of Insure® One™

13 Nov 2017

BRIEF-Quest Diagnostics acquires certain assets of California Laboratory Associates

* Quest Diagnostics acquires California Laboratory Associates

30 Oct 2017

BRIEF-Advantage Capital Portfolio company Cleveland Heartlab acquired by Quest Diagnostics

* Advantage Capital Portfolio company Cleveland Heartlab, Inc acquired by Quest Diagnostics

20 Oct 2017

BRIEF-Quest Diagnostics reports Q3 diluted eps of $1.15

* Quest Diagnostics reports third quarter 2017 financial results, updates 2017 financial guidance and reaffirms long term outlook

19 Oct 2017

Competitors

Earnings vs. Estimates